Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
PR Newswire
FARAPULSE’s Pivotal ADVENT Trial underway with First Patients Treated with its Breakthrough Pulsed Field Ablation System to Treat Atrial Fibrillation
March 3, 2021 -
GlobeNewswire
Tempest Therapeutics Announces Clinical Collaboration with Roche to Advance TPST-1120 into a Randomized Combination Study in First-line Hepatocellular Carcinoma
March 3, 2021 -
Business Wire
Rallybio Reveals Details of Two Pipeline Programs with the Potential to Transform the Lives of Patients with Rare Diseases
March 2, 2021 -
PR Newswire
Protenus Earned Designation as a Great Place to Work-Certified™ Company in 2021
March 2, 2021 -
Genomics plc
Genomics PLC Completes Oversubscribed $30M Funding Round
March 1, 2021 -
Endpoints News
Six years separated from a rabies vaccine scandal, China’s YishengBio grabs $130M to go big in infectious diseases, cancer
February 26, 2021 -
PR Newswire
Benchling Launches Pioneering Biology Education Initiative
February 25, 2021 -
PR Newswire
Independence Blue Cross and Quartet Health Collaborate to Address Behavioral Health
February 24, 2021 -
PR Newswire
Insilico Medicine Achieves Industry First Nominating Preclinical Candidate Discovered by AI
February 24, 2021 -
Endpoints News
Insilico preps first candidate for IND studies, hoping to launch trial in IPF by end of 2021
February 24, 2021 -
PR Newswire
Cone Health and Triad HealthCare Network Expand Partnership with PatientPing to Improve Patient Outcomes and Collaboration Amongst Providers
February 23, 2021 -
GlobeNewswire
Beam Therapeutics Announces Acquisition of Guide Therapeutics
February 23, 2021 -
PR Newswire
Centivo Expands its Health Plan into Connecticut
February 22, 2021 -
PR Newswire
Dr. Feng Ren Appointed as Chief Scientific Officer of Insilico Medicine
February 22, 2021 -
PR Newswire
The BCMA CAR-T Co-developed by Innovent and IASO Was Granted Breakthrough Therapy Designation by the NMPA for the Treatment of Relapsed/Refractory Multiple Myeloma
February 22, 2021 -
PR Newswire
PatientPing’s National Network of Accountable Care Organizations Earns Over $260 Million in Savings Under the Next Generation ACO Model
February 18, 2021 -
GlobeNewswire
Ultragenyx Announces Approval of Dojolvi™ (UX007/triheptanoin) in Canada for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Adults and Children
February 17, 2021 -
GlobeNewswire
Affinia Therapeutics Announces Addition of Gene Therapy Scientific and Medical Experts to Leadership Team to Advance Novel Gene Therapy Platform and Programs to the Clinic
February 17, 2021 -
MobiHealthNews
Care navigation platform Cohort scores $11M, Sitka lands $14M for specialty care telemedicine and other digital health fundings
February 16, 2021 -
GlobeNewswire
Denali Therapeutics Reports Positive Three-Month Data from Phase 1/2 Study with ETV:IDS (DNL310) in Patients with Hunter Syndrome (MPS II)
February 12, 2021 -
Business Wire
Ensoma Announces Strategic Collaboration with Takeda to Accelerate Next-Generation In Vivo Gene Therapies
February 11, 2021 -
Business Wire
Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First “Off-the-shelf” Genomic Medicines
February 11, 2021 -
PR Newswire
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
February 10, 2021 -
STAT
Equip, a startup providing virtual therapy for eating disorders, raises $13 million
February 10, 2021 -
GlobeNewswire
Orchard Therapeutics Announces Interim Data for OTL-203 Showing Positive Clinical Results in Multiple Disease Manifestations of Mucopolysaccharidosis Type I Hurler Syndrome (MPS-IH)
February 9, 2021 -
GlobeNewswire
Adagene Inc. Announces Pricing of Initial Public Offering
February 9, 2021 -
PR Newswire
Innovent Announces First Patient Dosed in Phase III Pivotal Trial of IBI310 (CTLA-4) Combined with TYVYT® (sintilimab injection) for the Treatment of First-line Advanced Hepatocellular Carcinoma
February 8, 2021 -
GlobeNewswire
Denali Therapeutics to Present New Data on ETV:IDS (DNL310) for the Potential Treatment of Hunter Syndrome at WORLDSymposium™
February 5, 2021 -
GlobeNewswire
Orchard Therapeutics Announces $150 Million Strategic Financing Strengthened Financial Position Supports Execution into the First Half of 2023
February 5, 2021 -
FierceBiotech
Biotech Sana snags $587.5M IPO to catapult cell therapies into the clinic
February 4, 2021 -
GlobeNewswire
Inmar Intelligence Adds Protenus to Continue Combatting Opioid Epidemic
February 4, 2021 -
Business Wire
Syngenta Crop Protection and Insilico Medicine to Harness Artificial Intelligence to Transform Sustainable Product Innovation
February 3, 2021 -
GlobeNewswire
Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences
February 2, 2021 -
PR Newswire
VitalCDM® Ranked #1 in KLAS Revenue Cycle, Chargemaster Management Category for Third Year in a Row
February 2, 2021 -
PR Newswire
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Pemetrexed and Platinum Chemotherapy as First-Line Therapy for Nonsquamous Non-Small Cell Lung Cancer
February 2, 2021 -
GlobeNewswire
Junshi Biosciences and Coherus BioSciences Announce Collaboration to Co-Develop Anti-PD-1 Antibody, Toripalimab, in U.S. and Canada
February 1, 2021 -
Business Wire
Exelixis and Adagene Enter into Collaboration and License Agreement to Develop Novel Masked Antibody-Drug Conjugate Therapies with Improved Safety and Efficacy Profiles
February 1, 2021 -
GlobeNewswire
Orchard Therapeutics Appoints Braden Parker as Chief Commercial Officer
January 29, 2021 -
GlobeNewswire
ONTOZRY™ (cenobamate) receives positive CHMP opinion for the adjunctive treatment of uncontrolled focal onset seizures in adults
January 29, 2021 -
PR Newswire
Farapulse Receives European Approval To Commercialize Its Leading Pulsed Field Ablation System To Treat Paroxysmal Atrial Fibrillation
January 29, 2021 -
Business Wire
SonderMind Adds Chief Financial and Chief Product Officer to Senior Management Team
January 28, 2021 -
GlobeNewswire
Acacia Pharma Launches BYFAVO™ (remimazolam) in the United States for Procedural Sedation in Adults Undergoing Medical Procedures Lasting 30 Minutes or Less
January 28, 2021 -
PR Newswire
Citrine Medicine Announces Strategic Partnership to bring Alkindi® to China for Use in Pediatric Congenital Adrenal Hyperplasia (CAH)
January 27, 2021 -
PR Newswire
Benchling Launches Validated Cloud to Accelerate Product Development for Life Sciences
January 26, 2021 -
PR Newswire
Hurdle Raises $5 Million Series Seed to Accelerate Expansion of its Mental Health Platform with Special Focus on the Black Community
January 25, 2021 -
GlobeNewswire
Ultragenyx Announces FDA Clearance of Investigational New Drug (IND) Application for UX701, a New Gene Therapy for the Treatment of Wilson Disease
January 21, 2021 -
PR Newswire
Avidity Biosciences Appoints W. Michael Flanagan, Ph.D. as Chief Technical Officer
January 21, 2021 -
PR Newswire
Iora Health Strengthens Executive Team with CFO and CGO Hires
January 20, 2021 -
Business Wire
Turnstone Biologics Acquires Novel Cell Therapy Platform
January 20, 2021 -
GlobeNewswire
Acacia Pharma wins BEL Small Company of the Year for the second consecutive year
January 20, 2021 -
FierceBiotech
Adagene plans $125M IPO to go after cancer niches targeted by BMS and Pfizer
January 20, 2021 -
GlobeNewswire
Precision BioSciences Announces FDA Accepts IND for PBCAR19B, a Next-Generation, Stealth Cell, CD19 Allogeneic CAR T Candidate for Non-Hodgkin Lymphoma
January 19, 2021 -
Business Wire
Verve Therapeutics Secures $94 Million in Series B Financing to Advance Pipeline of Gene Editing Medicines for Cardiovascular Disease
January 19, 2021 -
GlobeNewswire
Orchard Therapeutics Secures Partnerships to Broaden Access to LibmeldyTM for Eligible Patients in Middle East & Turkey
January 19, 2021 -
PR Newswire
Innovent Announces an Out-license Agreement with PT Etana Biotechnologies Indonesia to Launch BYVASDA® (Bevacizumab Biosimilar) in Indonesia
January 18, 2021 -
PR Newswire
Notable Health First to Launch Automated Identification and Engagement of Patients Eligible for COVID-19 Vaccine
January 14, 2021 -
Business Wire
Kyruus Enables Online Scheduling for COVID-19 Vaccine Visits and Facilitates More Than 100,000 Appointments in the First Month
January 14, 2021 -
Business Wire
Novaerus Defend 1050 Cleared by FDA as 510(k) Class II Medical Device to Inactivate and Filter Out Airborne Virus and Bacteria for Medical Purposes
January 14, 2021 -
PR Newswire
Benchling Doubles Annual Recurring Revenue (ARR) for Fourth Straight Year Amid COVID-19 Pandemic
January 14, 2021 -
GlobeNewswire
Orchard Therapeutics Announces OTL-200 Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by FDA for the Treatment of Metachromatic Leukodystrophy (MLD)
January 14, 2021 -
Endpoints News
Adaptimmune ‘ready for primetime’ as it prepares to launch T cell therapy for sarcoma, CEO Adrian Rawcliffe says
January 13, 2021 -
BioSpace
Emerging Seattle-Based Sana Biotechnology Seeks to Raise $150 Million IPO
January 13, 2021 -
PR Newswire
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab as Second-Line Therapy for Squamous Non-Small Cell Lung Cancer
January 12, 2021 -
FierceBiotech
Verve Therapeutics unveils its lead program—a one-and-done treatment for genetic high cholesterol
January 12, 2021 -
GlobeNewswire
Adagene Announces Milestone of CAR-T Collaboration with the National Heart, Lung, and Blood Institute at the National Institutes of Health
January 12, 2021 -
PR Newswire
Centivo Expands Health Partnerships in New York and New Jersey
January 12, 2021 -
FierceBiotech
Biogen, Genentech and F-Prime power new neurodegenerative biotech to $110M unveiling
January 11, 2021 -
GlobeNewswire
Orchard Therapeutics Announces 2021 Corporate Priorities Supporting the Build-out of its Commercial Business in Hematopoietic Stem Cell (HSC) Gene Therapy and Expansion of its Clinical Applications
January 11, 2021 -
PR Newswire
Avidity Biosciences Announces Changes to its Board of Directors
January 11, 2021 -
GlobeNewswire
Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors
January 11, 2021 -
GlobeNewswire
Beam Therapeutics Appoints Leading Healthcare Executive Kate Walsh to its Board of Directors
January 11, 2021 -
PR Newswire
Sana Biotechnology Announces Appointments to its Board of Directors
January 8, 2021 -
PR Newswire
Avidity Biosciences Announces 2021 Pipeline Updates and Research Collaboration with MyoKardia
January 8, 2021 -
GlobeNewswire
Denali Therapeutics Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Broad Therapeutic Portfolio in Neurodegeneration
January 8, 2021 -
GlobeNewswire
Precision BioSciences Announces Closing of In Vivo Gene Editing Collaboration and License Agreement with Eli Lilly and Company
January 7, 2021 -
GlobeNewswire
Coherus BioSciences Appoints Alan Mendelson and Mark Stolper to Board of Directors
January 7, 2021 -
PR Newswire
Sana Biotechnology Builds Key Regulatory Capabilities as Ke Liu, M.D., Ph.D., Joins Senior Leadership Team
January 6, 2021 -
PR Newswire
Cigna Adds Iora Health to Growing Medicare Advantage Network
January 6, 2021 -
PR Newswire
Angelini Pharma acquires Arvelle Therapeutics to create a leading European innovator in Central Nervous System (CNS) and Mental Health Disorder treatments
January 4, 2021 -
PR Newswire
Innovent Announces the NMPA Granted New Indication Approval for BYVASDA® (Bevacizumab Biosimilar) for the Treatment of Adult Recurrent Glioblastoma
December 27, 2020 -
GlobeNewswire
Orchard Therapeutics Receives EC Approval for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
December 21, 2020 -
PR Newswire
FARAPULSE’s Pivotal Trial to Assess Its Leading Pulsed Field Ablation System for The Treatment of Atrial Fibrillation Receives FDA Conditional Approval
December 17, 2020 -
Business Wire
Kyruus and HealthSparq Come Together to Transform Care Navigation Through Novel Payer-Provider Collaboration
December 17, 2020 -
Endpoints News
GlaxoSmithKline plumbs the discovery field (again), betting up to $815M for the latest add-on to its oncology pipeline
December 17, 2020 -
PR Newswire
Blueprint Medicines Submits Supplemental New Drug Application to FDA for AYVAKIT™ (avapritinib) for the Treatment of Advanced Systemic Mastocytosis
December 17, 2020 -
Business Wire
NodThera Appoints Chief Medical Officer and Chief Financial Officer
December 15, 2020 -
PR Newswire
Innovent Announces First Patient Dosed in Phase 2 Pivotal Trial of IBI310 (CTLA-4) combined with TYVYT® (sintilimab injection) for the treatment of second-line or above Advanced Cervical Cancer
December 10, 2020 -
GlobeNewswire
Ultragenyx Announces Orphan Drug Designation for UX701 for the Treatment of Wilson Disease
December 9, 2020 -
GlobeNewswire
Orchard Therapeutics Reports OTL-201 Initial Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA)
December 8, 2020 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate CMP-001 in Combination with Nivolumab
December 8, 2020
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.